Free Shipping All Orders From 200 Limited Time Offer
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
DDAVP 2.5ml spray 10 mcg

DDAVP 2.5ml spray 10 mcg

Customer rating: 4.9 out of 5
Availability: In Stock 75 packs
Active ingredient: DESMOPRESSIN

DDAVP® Nasal Spray (desmopressin acetate) is a synthetic analogue of the natural pituitary hormone 8-arginine vasopressin (ADH), an antidiuretic hormone affecting renal water conservation.

We accept:
VISA
MasterCard
PayPal
SEPA
Discover
Amex
BTC
USDT
Delivery options:
EMS
$29.95
Delivery period: 3-8 days
Tracking# available in 3 days
Airmail
$12.95
Delivery period: 14-21 days
Tracking# available in 14 days

DDAVP 2.5ml spray 10 mcg 2.5ml

Package Per pill Total price Save Order
2.5ml × 1 Sprayers $67.49 $67.49 -
2.5ml × 2 Sprayers $60.75 $121.49 $13.48
2.5ml × 3 Sprayers $58.20 $174.59 $27.87
2.5ml × 4 Sprayers $55.80 $223.19 FreeTrackable Delivery $46.76
2.5ml × 8 Sprayers $54.22 $433.79 FreeTrackable Delivery $106.16

Package Example

Your order will be packed safe and secure and dispatched within 24 hours. This is exactly how your parcel will look like (pictures of a real shipping item). It has a size and a look of a regular private letter (9.4x4.3x0.3 inches or 24x11x0.7cm) and it does not disclose its contents

Front view
Front view
Side view
Side view
Back view
Back view

Drug uses

Central Cranial Diabetes Insipidus: DDAVP Nasal Spray (desmopressin acetate nasal spray) is indicated as antidiuretic replacement therapy in the management of central cranial diabetes insipidus and for management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. It is ineffective for the treatment of nephrogenic diabetes insipidus.

The use of DDAVP Nasal Spray (desmopressin acetate nasal spray) in patients with an established diagnosis will result in a reduction in urinary output with increase in urine osmolality and a decrease in plasma osmolality. This will allow the resumption of a more normal life-style with a decrease in urinary frequency and nocturia.

There are reports of an occasional change in response with time, usually greater than 6 months. Some patients may show a decreased responsiveness, others a shortened duration of effect. There is no evidence this effect is due to the development of binding antibodies but may be due to a local inactivation of the peptide.

Patients are selected for therapy by establishing the diagnosis by means of the water deprivation test, the hypertonic saline infusion test, and/or the response to antidiuretic hormone. Continued response to intranasal DDAVP can be monitored by urine volume and osmolality.

DDAVP is also available as a solution for injection when the intranasal route may be compromised. These situations include nasal congestion and blockage, nasal discharge, atrophy of nasal mucosa, and severe atrophic rhinitis. Intranasal delivery may also be inappropriate where there is an impaired level of consciousness. In addition, cranial surgical procedures, such as transsphenoidal hypophysectomy create situations where an alternative route of administration is needed as in cases of nasal packing or recovery from surgery.

Overdosage

Signs of overdose may include confusion, drowsiness, continuing headache, problems with passing urine and rapid weight gain due to fluid retention. In case of overdosage, the dose should be reduced, frequency of administration decreased, or the drug withdrawn according to the severity of the condition. There is no known specific antidote for desmopressin acetate or DDAVP Nasal Spray.

An oral LD50 has not been established. An intravenous dose of 2 mg/kg in mice demonstrated no effect.

Storage

Store at Controlled Room Temperature 20 to 25°C (68 to 77°F). STORE BOTTLE IN UPRIGHT POSITION.

Keep out of the reach of children.

Safety information


Warnings

  1. For intranasal use only.
  2. DDAVP Nasal Spray (desmopressin acetate nasal spray) should only be used in patients where orally administered formulations are not feasible.
  3. Very rare cases of hyponatremia have been reported from world-wide postmarketing experience in patients treated with DDAVP (desmopressin acetate). DDAVP is a potent antidiuretic which, when administered, may lead to water intoxication and/or hyponatremia. Unless properly diagnosed and treated hyponatremia can be fatal. Therefore, fluid restriction is recommended and should be discussed with the patient and/or guardian. Careful medical supervision is required.
  4. When DDAVP Nasal Spray (desmopressin acetate nasal spray) is administered, in particular in pediatric and geriatric patients, fluid intake should be adjusted downward in order to decrease the potential occurrence of water intoxication and hyponatremia. All patients receiving DDAVP therapy should be observed for the following signs or symptoms associated with hyponatremia: headache, nausea/vomiting, decreased serum sodium weight gain, restlessness, fatigue, lethargy, disorientation, depressed reflexes, loss of appetite, irritability, muscle weakness, muscle spasms or cramps and abnormal mental status such as hallucinations, decreased consciousness and confusion. Severe symptoms may include one or a combination of the following: seizure, coma and/or respiratory arrest. Particular attention should be paid to the possibility of the rare occurrence of an extreme decrease in plasma osmolality that may result in seizures which could lead to coma.
  5. DDAVP should be used with caution in patients with habitual or psychogenic polydipsia who may be more likely to drink excessive amounts of water, putting them at greater risk of hyponatremia.

Disclaimer

The information on this page is not intended to be a substitute for professional medical advice. Do not use this information to diagnose or treat your problem without consulting your doctor.

Side effects


Infrequently, high dosages of intranasal DDAVP have produced transient headache and nausea. Nasal congestion, rhinitis and flushing have also been reported occasionally along with mild abdominal cramps. These symptoms disappeared with reduction in dosage. Nosebleed, sore throat, cough and upper respiratory infections have also been reported.

Viagra Oral Jelly
Bestsellers
Viagra Oral Jelly Erectile Dysfunction
/ 4.9 out of 5
$2.12 Per pill
Delivery period: 3-8 days
|
Ships to United States
Add to cart
Cialis Oral Jelly (Orange)
Today’s sale
Cialis Oral Jelly (Orange) Erectile Dysfunction
/ 4.9 out of 5
$2.84 Per pill
Delivery period: 3-8 days
|
Ships to United States
Add to cart
Viagra Oral Jelly
Viagra Oral Jelly Erectile Dysfunction
/ 4.9 out of 5
$2.12 Per pill
Delivery period: 3-8 days
|
Ships to United States
Add to cart
Cialis Oral Jelly (Orange)
Cialis Oral Jelly (Orange) Erectile Dysfunction
/ 4.9 out of 5
$2.84 Per pill
Delivery period: 3-8 days
|
Ships to United States
Add to cart
Free Regmail
All Orders From $200
*Limited Time Offer
Free EMS Regmail
All Orders From $200
*Limited Time Offer
1M+ Customers
Quality, Privacy, Secure.
Very Low Prices
Best price in the world!
Fast Delivery
100% Guarantee. Free Airmail shipping.